Literature DB >> 17167835

Treatment of hyperbilirubinemia with blood purification in China.

Zhi-Jun Duan1, Lei-Lei Li, Jia Ju, Zhi-Hong Gao, Gao-Hong He.   

Abstract

The incidence of hyperbilirubinemia is high clinically, which is difficult to cure by medication, surgery or interventional therapies. Non-bioartificial liver is the main alternative in the blood purification for hyperbilirubinemia, which includes plasma exchange, hemoperfusion, hemodialysis, molecular adsorbent recycling system and so on. The research results and clinical experiences in China show that these methods are effective in lowering high levels of bilirubin with fewer side effects. The hyperbilirubinemias of different causes, with different complications or accompanying different diseases can be treated by different methods. Bioartificial liver, hybrid artificial liver support system and adsorbent membrane material have also been studied and their development in reducing hyperbilirubinemias has been achieved. This article gives a brief overview on the actuality and research improvement in blood purification for hyperbilirubinemia in China.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17167835      PMCID: PMC4087592          DOI: 10.3748/wjg.v12.i46.7467

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

1.  Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease.

Authors:  L M Forman; M R Lucey
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

2.  Adsorption of bilirubin by amine-containing crosslinked chitosan resins.

Authors:  Y Yu; B He; H Gu
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2000-07

3.  Membrane cartridges for endotoxin removal from interferon preparations.

Authors:  Jinghua Li; Yingguang Shao; Zhaoan Chen; Runzi Cong; Junde Wang; Xueliang Liu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-07-05       Impact factor: 3.205

4.  [Study of severe hepatitis treated with a hybrid artificial liver support system].

Authors:  Lan-juan Li; Qian Yang; Jian-rong Huang; Jun Li; Hong-cui Cao; Yue-mei Chen; Ya-gang Chen; Ji-fang Cheng; Su-zhen Fu
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2003-08

5.  [Effects of artificial liver support system on chronic sever hepatitis patients].

Authors:  Jia Shang; Bai-ling Jia; He-ping Zhang; Ping Chen; Xiu Jin
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2003-08

6.  [Treatment of severe hepatitis by artificial liver support system].

Authors:  Quan Ming; Shao-qing Qiu; Chang-yin Chen; Sheng-xiang Luo; Jie Zhou; Ling Bai
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2004-05

7.  Bioartificial liver: current status.

Authors:  G Pless; I M Sauer
Journal:  Transplant Proc       Date:  2005-11       Impact factor: 1.066

8.  [Preliminary evaluation on the effects of a hybrid bioartificial liver support system in the treatment of hepatic failure].

Authors:  Ying-jie Wang; Nian-hai He; Run-zhang Niu; Jun Liu; Hong-wei Wen; Jia-jia Li; Yu-ming Wang
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2003-08

9.  [Change of blood parameters in liver failure patients with severe hepatitis after combined therapy].

Authors:  Jia-hao Lin; Yan-xue Guo; Xiu-hua Zhou; Fang-shu Chen
Journal:  Zhongguo Wei Zhong Bing Ji Jiu Yi Xue       Date:  2003-02

10.  [Novel affinity membrane used for bilirubin removal].

Authors:  G L Wei; Z H Shang; Y N Yu; X L Liu; Z H Gao; M C Pan
Journal:  Se Pu       Date:  2001-01
View more
  1 in total

Review 1.  Therapeutic Efficacy and Safety of Paeoniae Radix Rubra Formulae in Relieving Hyperbilirubinemia Induced by Viral Hepatitis: A Meta-Analysis.

Authors:  Yin-Qiu Huang; Xiao Ma; Jian Wang; Yan-Ling Zhao; Jia-Bo Wang; Zhe Chen; Yun Zhu; Li-Mei Shan; Shi-Zhang Wei; Ji Wang; Xiao-He Xiao
Journal:  Front Pharmacol       Date:  2016-03-22       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.